UFIS-SWE-IG
0.1.0 - ci-build

UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions

Example RegulatedAuthorization: Xyloproct-RectalOintment-SE-AJ-RA

Generated Narrative: RegulatedAuthorization Xyloproct-RectalOintment-SE-AJ-RA

identifier: http://ema.europa.eu/fhir/marketingAuthorizationNumber/8340

subject: MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100001718-00008340,http://ema.europa.eu/fhir/eurdId#1679; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Rectal ointment; indication = Xyloproct rektalsalva och Xyloproct suppositorier är avsedda för behandling av vuxna. Behandling av hemorrojder, analtenesmer och analfissurer samt postoperativt efter anorektala ingrepp eller i samband med anorektala explorationer. För egenvård: hemorrojder och ytliga ändtarmsirritationer.; legalStatusOfSupply = Medicinal product not subject to medical prescription; classification = hydrocortisone

type: Marketing Authorisation

region: Kingdom of Sweden

status: Valid

statusDate: 1969-01-24

holder: Organization Aspen Pharma Trading Limited

Cases

-TypeDate[x]
*First Authorisation1969-01-24